Comparison of meglumine antimoniate and pentamidine for Peruvian cutaneous leishmaniasis

American Journal of Tropical Medicine and Hygiene

Volumn 72, Issue 2, 2005, Pages 133-137

  Andersen, Ellen M ^a   Cruz Saldarriaga, Maria ^b   Llanos Cuentas, Alejandro ^c   Luz Cjuno, Maria ^d   Echevarria, Juan ^c   Miranda Verastegui, Cesar ^c   Colina, Olga ^d   Berman, Jonathan D ^e  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b Hospital Instituto Peruano Seguro Social   (Peru)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^d California   (Peru)

^e National Institutes of Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME; MEGLUMINE ANTIMONATE; PANCREAS ENZYME; PENTAMIDINE; PENTAMIDINE ISETHIONATE; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

ABDOMINAL PAIN; ADULT; ARTHRALGIA; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DRUG TOLERABILITY; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; ISCHIALGIA; LEISHMANIA BRAZILIENSIS; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; MYALGIA; NAUSEA; PAIN; PARESTHESIA; PERU; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SKIN LEISHMANIASIS; TREATMENT FAILURE; VOMITING; ANIMAL; BLOOD; COMPARATIVE STUDY; INTRAVENOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

LEISHMANIA BRAZILIENSIS;

ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PENTAMIDINE; PERU; TREATMENT OUTCOME;

EID: 15844394149     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2005.72.133     Document Type: Article

References (13)

1. Herwaldt BL, Berman JD. 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 46: 296-306.
2. Soto-Mancipe J, Grogl M, Berman JD. 1993. Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. Clin Infect Dis 16: 417-425.
3. Velez I, Agudelo S, Hendrickx E, Puerta J, Grogl M, Modabber F, Berman J. 1997. Inefficacy of Allopurinol for Colombian cutaneous leishmaniasis: a randomized, controlled trial. Ann Intern Med 126: 232-236.
4. Aronson NE, Wortmann GW, Johnson SC, Jackson JE, Gasser RA Jr, Magill AJ, Endy TP, Coyne PE, Grogl M, Benson PM, Beard JS, Tally JD, Gambel JM, Kreutzer RD, Oster CN, 1998. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis 27: 1457-1464.
5. Gasser RA Jr, Magil AJ, Oster CN, Franke ED, Grogl M, Berman JD. 1994. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin Infect Dis 18: 83-90.
6. Low-A-Chee RM, Rose P, Ridley DS. 1983. An outbreak of cutaneous leishmaniasis in Guyana: epidemiology, clinical and laboratory aspects. Ann Trop Med Parasitol 77: 255-260.
7. Berman JD, Wyler DJ. 1980. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. J Infect Dis 142: 83-86.
8. Davey RT, Masur H. 1990. Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother 34: 499-504.
9. Kreutzer RD, Semko ME, Hendricks LD, Wright N. 1983. Identification of Leishmania spp. by multiple isozyme analysis. Am J Trop Med Hyg 32: 703-715.
10. Common Toxicity Criteria of the US National Cancer Institute. CTC Criteria version 2.0: http://ctcp.info.nih.gov. The CTC criteria are now called CTCAE version 3.0.
11. Lucas CM, Franke ED, Cachay MI, Tejada A, Cruz ME, Kreutzer RD, Barker DC, McCann SH, Watts DM. 1998. Geographic distribution and clinical description of leishmaniasis cases in Peru. Am J Trop Med Hyg 59: 312-317.
12. Mendonca MG, de Brito ME, Rodrigues EH, Bandeira V, Jardim ML, Abath FG. 2004. Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J Infect Dis 189: 1018-1023.
13. Lai A, Fat EJSK, Vrede MA, Soetosenojo RM, Lai A, Fat RFM. 2002. Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam. Int J Dermatol 41: 796-800.